Variant:
rs1051296 at chr21:46934861 in COL18A1, SLC19A1 (VIP)

Alleles (on + chromosomal strand)
A > C
Alternate Names:
c.*711T>G, g.114756A>C, g.3929302A>C

VIP Variant in SLC19A1

Note: The SLC19A1 gene is found on the minus chromosomal strand. Please note that for standardization, the PharmGKB presents all allele base pairs on the positive chromosomal strand, therefore the alleles within our variant annotations may differ (in a complementary manner) from those in this VIP summary that are given on the minus strand as reported in the literature.


This variant in the 3'-UTR region of SLC19A1 showed high allele frequencies (40 - 50%) in all HapMap populations. Potentially, a SNP located within the 3'-untranslated region (UTR), which contains regulatory sequences and binding sites for other molecules that could alter the stability of the mRNA transcript of the gene. However, this SNP has not been functionally characterized although this SNP has been genotyped and assessed for its effect on non-Hodgkin lymphoma (NHL) among over 1000 cases and 949 population-based controls [Article:17119116]. There is no significant association of this variant with risk of NHL.

Key Publications:

Appendix

4. SLC19A1: 3'-UTR ; 2606G>T (rs1051296)

Genomic Variant & GenBank ID: 3929302A>C on NT_011515.12
mRNA Variant & GenBank ID: 2606G>T on NM_19455.1
Protein Variant & GenBank ID: NA
GoldenPath Position: chr21:45759289 (hg18)

Publications related to rs1051296 at chr21:46934861: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available VIP No VIP available
Gene-nutrient interactions among determinants of folate and one-carbon metabolism on the risk of non-Hodgkin lymphoma: NCI-SEER case-control study. Blood. 2007. Lim Unhee, et al. [Article:17119116@PubMed]

Cross-References

UCSC Golden Path:
chr21:46934861
dbSNP:
rs1051296
HapMap:
rs1051296
JSNP:
IMS-JST006715

Platform Availability

  • Illumina

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.